---

Related Articles:

Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?

2013-10-01

[Obstet. Gynecol. Clin. North Am. 21(2) , 299-319, (1994)]

Activation of NF-kappaB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens.

1980-03-01

[Gynecol. Endocrinol. 26(4) , 265-9, (2010)]

17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.

2012-08-01

[Gynecol. Endocrinol. 28(8) , 606-10, (2012)]

Phase of oral contraceptive cycle and endurance capacity of rowers.

2011-12-01

[Percept. Mot. Skills 113(3) , 764-72, (2011)]

Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.

2012-01-01

[J. Fam. Plann. Reprod. Health Care 38(1) , 2-6, (2012)]